ASX - By Stock
|
MSB |
Re:
MSB CR
|
|
yelrom
|
11 |
3.8K |
8 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
11
|
3.8K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Red Red Whine
|
|
yelrom
|
58 |
20K |
6 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
58
|
20K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
3 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
905
|
286K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
5 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
905
|
286K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
28 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
905
|
286K
|
28
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
yelrom
|
10K |
3.0M |
29 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
USD573M in retained losses and a less than great 2020!. 2021 a year that cannot get worse
|
|
yelrom
|
311 |
91K |
25 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
311
|
91K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Lonza - Cell Technology - The Cocoon
|
|
yelrom
|
3 |
1.8K |
3 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
3
|
1.8K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
USD573M in retained losses and a less than great 2020!. 2021 a year that cannot get worse
|
|
yelrom
|
311 |
91K |
29 |
05/01/21 |
05/01/21 |
ASX - By Stock
|
311
|
91K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
MSB Short Position Reporting
|
|
yelrom
|
255 |
83K |
6 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
255
|
83K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Short Position Reporting
|
|
yelrom
|
255 |
83K |
13 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
255
|
83K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
yelrom
|
273 |
141K |
15 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
273
|
141K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
yelrom
|
273 |
141K |
41 |
01/01/21 |
01/01/21 |
ASX - By Stock
|
273
|
141K
|
41
|
|
ASX - By Stock
|
MSB |
Re:
Do you still think Mesoblast will be the next CSL?
|
|
yelrom
|
155 |
66K |
7 |
31/12/20 |
31/12/20 |
ASX - By Stock
|
155
|
66K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
yelrom
|
1.0K |
418K |
10 |
24/12/20 |
24/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
CHF - The real phase 3 headlines
|
|
yelrom
|
147 |
73K |
24 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
147
|
73K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
12 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
4 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
something must be brewing
|
|
yelrom
|
112 |
45K |
6 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
112
|
45K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Irrational gloom
|
|
yelrom
|
64 |
28K |
32 |
20/12/20 |
20/12/20 |
ASX - By Stock
|
64
|
28K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
yelrom
|
1.0K |
517K |
4 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Irrational gloom
|
|
yelrom
|
64 |
28K |
43 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
64
|
28K
|
43
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
yelrom
|
183 |
94K |
2 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
94K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
yelrom
|
183 |
94K |
21 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
94K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
2 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
7 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
16 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
yelrom
|
1.0K |
517K |
0 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
yelrom
|
1.0K |
517K |
2 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
yelrom
|
1.0K |
517K |
14 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
yelrom
|
1.0K |
517K |
39 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
39
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
yelrom
|
905 |
286K |
8 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
905
|
286K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
4 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
yelrom
|
1.0K |
418K |
33 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
yelrom
|
1.0K |
418K |
27 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
yelrom
|
1.0K |
418K |
24 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
yelrom
|
1.0K |
418K |
46 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
46
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
yelrom
|
1.0K |
418K |
2 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
yelrom
|
344 |
180K |
16 |
13/12/20 |
13/12/20 |
ASX - By Stock
|
344
|
180K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
yelrom
|
344 |
180K |
32 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
344
|
180K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
yelrom
|
344 |
180K |
51 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
344
|
180K
|
51
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
yelrom
|
425 |
190K |
30 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
425
|
190K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
yelrom
|
425 |
190K |
2 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
425
|
190K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
53 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
53
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
7 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
yelrom
|
572 |
252K |
6 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
572
|
252K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Reduces Biomarkers for Mortality in SR-aGVHD
|
|
yelrom
|
139 |
72K |
53 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
139
|
72K
|
53
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
8 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
10 |
06/12/20 |
06/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
9 |
06/12/20 |
06/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
9
|
|